Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/9013| Title: | Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery | Authors: | Goodman, Shaun G Aylward, Philip E Szarek, Michael Chumburidze, Vakhtang Bhatt, Deepak L Bittner, Vera A Diaz, Rafael Edelberg, Jay M Hanotin, Corinne Harrington, Robert A Jukema, J Wouter Kedev Sasko Letierce, Alexia Moryusef, Angele Pordy, Robert Ramos López, Gabriel Arturo Roe, Matthew T Viigimaa, Margus White, Harvey D Zeiher, Andreas M Steg, Ph Gabriel Schwartz, Gregory G |
Issue Date: | 2019 | Publisher: | Elsevier BV | Journal: | Journal of the American College of Cardiology | Abstract: | Patients with acute coronary syndrome (ACS) and history of coronary artery bypass grafting (CABG) are at high risk for recurrent cardiovascular events and death. | URI: | http://hdl.handle.net/20.500.12188/9013 | DOI: | 10.1016/j.jacc.2019.07.015 |
| Appears in Collections: | Faculty of Medicine: Journal Articles |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.